Nine Phase One (mannote sodium) - Shanghai Greenvalley
masupirdine (SUVN-502) - Suven Life Sci
tilavonemab (ABBV-8E12) - AbbVie
Aduhelm (aducanumab) - Neurimmune, Eisai
semorinemab (RG6100) - AC Immune
gosuranemab (BIIB092) - Biogen
Leqembi (lecanemab-irmb) - Biogen, Eisai
zagotenemab (LY3303560) - Eli Lilly
Kisunla (donanemab-azbt) - Eli Lilly
http://www.ncbi.nlm.nih.gov/pubmed/41929952
 
Shanshan Huang; Yunyun Guo
 
Apr 3, 2026
 
Prev Next